References
Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28:S67–72.
Straughan DM, McLoughlin KC, Mullinax JE, et al. The changing paradigm of management of liver abscesses in chronic granulomatous disease. Clin Infect Dis. 2018;66:1427–34.
Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology. 2007;45:675–83.
Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, et al. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol. 2004;172:636–43.
de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. PNAS. 2014;111:3526–31.
Hahn KJ, Ho N, Yockey L, Kreuzberg S, Daub J, Rump A, et al. Treatment with anakinra, a recombinant IL-1 receptor antagonist, unlikely to induce lasting remission in patients with CGD colitis. Am J Gastroenterol. 2015;110:938–9.
Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease—related colitis. Clin Infect Dis. 2010;51:1429–34.
Availability of Data and Material
From patient’s clinical record
Code Availability
MS Office 365, licensed to Queensland Health
Author information
Authors and Affiliations
Contributions
CT and LD were involved in the clinical care of the patient and wrote the article. AW was involved in the genetic testing of the patient and family members. All authors have given their approval of the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Statement of Informed Consent
The patient has provided written informed consent for the publication of this case report including the images.
Ethics Approval
Not applicable.
Consent to Participate
See above under “Statement of Informed Consent”.
Consent for Publication
Refer also to “Statement of Informed Consent” above. The patient and their family have consented to the submission of the case report to the Journal, including publishing their data and results.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
To, C., Williams, A. & Droney, L. Anakinra for Treatment of Liver Abscesses in a Patient with a Novel CYBB Variant of Chronic Granulomatous Disease. J Clin Immunol 41, 1368–1371 (2021). https://doi.org/10.1007/s10875-021-01028-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-021-01028-0